Todd A. Trapp - 29 May 2021 Form 4 Insider Report for ABIOMED INC

Role
Vice President, CFO
Signature
/s/ Ian W. McLeod (by power of attorney)
Issuer symbol
N/A
Transactions as of
29 May 2021
Net transactions value
-$147,412
Form type
4
Filing time
02 Jun 2021, 16:40:01 UTC
Previous filing
27 May 2021
Next filing
05 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock, $0.01 par value Tax liability $147,412 -518 -5.1% $284.58 9,637 29 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABMD Stock Option (Right to Buy) 7,000 29 May 2021 Common Stock 0 $266.39 Direct F2, F3
holding ABMD Stock Option (right to buy) 6,530 29 May 2021 Common Stock 0 $223.90 Direct F2, F3
holding ABMD Stock Option (right to buy) 3,737 29 May 2021 Common Stock 0 $283.88 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
F2 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F3 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.